PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $80,000 | -44.4% | 12,800 | -53.8% | 0.00% | – |
| Q2 2020 | $144,000 | -8.9% | 27,682 | -44.8% | 0.00% | – |
| Q1 2020 | $158,000 | -21.8% | 50,115 | 0.0% | 0.00% | – |
| Q4 2019 | $202,000 | -7.3% | 50,115 | -0.7% | 0.00% | – |
| Q3 2019 | $218,000 | +10.1% | 50,465 | +1.4% | 0.00% | – |
| Q2 2019 | $198,000 | -27.5% | 49,750 | -2.5% | 0.00% | – |
| Q1 2019 | $273,000 | +6.6% | 51,050 | +2.3% | 0.00% | – |
| Q4 2018 | $256,000 | -69.3% | 49,910 | -41.9% | 0.00% | – |
| Q3 2018 | $833,000 | +44.6% | 85,862 | +52.1% | 0.00% | – |
| Q2 2018 | $576,000 | -12.5% | 56,462 | +11.6% | 0.00% | – |
| Q1 2018 | $658,000 | -4.2% | 50,607 | +31.9% | 0.00% | – |
| Q4 2017 | $687,000 | +29.4% | 38,378 | +81.6% | 0.00% | – |
| Q3 2017 | $531,000 | -54.4% | 21,131 | -56.3% | 0.00% | -100.0% |
| Q2 2017 | $1,164,000 | – | 48,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |